WuXi and MedImmune Form a Strategic Alliance to Develop Innovative Biologics in China for...

We are pleased to announce that we have formed a strategic alliance with MedImmune, the global biologics research and development arm of AstraZeneca to bring cutting-edge research and technical capability for...

WuXi Receives 2015 Open-Access R&D Technology Leadership Award from Frost & Sullivan

We are thrilled to share with you that we have been awarded the 2015 Frost & Sullivan North American Open-Access R&D Technology Leadership Award.  The award is part of Frost &...

Global WuXi Webinar: Pioneering Approaches to Dismantling Cancer

Significant advances have been made to unravel cancer’s mysteries and complexities at the genetic, molecular, and pathway levels. These advances not only reveal new scientific insights into the biology of the...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

China Market Authorization Holder System Summit 2017 Recap

More than 300 professionals gathered at the recent China Marketing Authorization Holder (MAH) System Summit to learn from government agencies, life science research and...